Skip to content

Clinical trials

Observational Muscular Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Muscular Diseases Phase: Observational Country / region: United States Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20041
20072
20092
20101
20111
20122
20133
20161
20171
20186
20221
20241
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Recruiting8
Terminated2
Active, not recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Neurological Disorders and Stroke (NINDS)6
Beth Israel Deaconess Medical Center3
University of California, Irvine3
Vanderbilt University Medical Center3
BioMarin Pharmaceutical1
Calcilytix Therapeutics, Inc., a BridgeBio company1
Clinic for Special Children1
Duke University1
Endo USA Inc., a Keenova Therapeutics Company1
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Muscular Diseases30
Musculoskeletal Diseases6
Muscular Dystrophies5
Neuromuscular Diseases5
Amyotrophic Lateral Sclerosis3
Muscle Hypertonia3
Muscle Spasticity3
Muscle Weakness3
Myositis3
Nervous System Diseases3

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.